相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Rechanneling the cardiac proarrhythmia safety paradigm: A meeting report from the Cardiac Safety Research Consortium
Philip T. Sager et al.
AMERICAN HEART JOURNAL (2014)
Binding kinetics differentiates functional antagonism of orexin-2 receptor ligands
R. Mould et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Cardiac safety assays
Jordi Heijman et al.
CURRENT OPINION IN PHARMACOLOGY (2014)
13th Annual Meeting of the Safety Pharmacology Society: focus on novel technologies and safety pharmacology frontiers
Icilio Cavero
EXPERT OPINION ON DRUG SAFETY (2014)
hERG Inhibitors with Similar Potency But Different Binding Kinetics Do Not Pose the Same Proarrhythmic Risk: Implications for Drug Safety Assessment
Giovanni Y. di Veroli et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2014)
The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands
Adam J. Pawson et al.
NUCLEIC ACIDS RESEARCH (2014)
Allosteric modulators of the hERG K+ channel Radioligand binding assays reveal allosteric characteristics of dofetilide analogs
Zhiyi Yu et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2014)
Observed Drug-Receptor Association Rates Are Governed by Membrane Affinity: The Importance of Establishing Micro-Pharmacokinetic/Pharmacodynamic Relationships at the β2-Adrenoceptor
David A. Sykes et al.
MOLECULAR PHARMACOLOGY (2014)
Thermodynamic and kinetic characterization of hydroxyethylamine β-secretase-1 inhibitors
Kalyani Mondal et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
THE CONCISE GUIDE TO PHARMACOLOGY 2013/14: ION CHANNELS
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
THE CONCISE GUIDE TO PHARMACOLOGY 2013/14: G PROTEIN-COUPLED RECEPTORS
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Molecular determinants of drug-receptor binding kinetics
Albert C. Pan et al.
DRUG DISCOVERY TODAY (2013)
Pharmacokinetics and the drug-target residence time concept
Goran Dahl et al.
DRUG DISCOVERY TODAY (2013)
A history of the role of the hERG channel in cardiac risk assessment
David Rampe et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2013)
Conformational Selection or Induced Fit? A Critical Appraisal of the Kinetic Mechanism
Austin D. Vogt et al.
BIOCHEMISTRY (2012)
Slow receptor dissociation is not a key factor in the duration of action of inhaled long-acting ß2-adrenoceptor agonists
David A. Sykes et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Functional efficacy of adenosine A2A receptor agonists is positively correlated to their receptor residence time
Dong Guo et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Understanding of Molecular Substructures that Contribute to hERG K+ Channel Blockade: Synthesis and Biological Evaluation of E-4031 Analogues
Maris Vilums et al.
CHEMMEDCHEM (2012)
hERG K+ CHANNELS: STRUCTURE, FUNCTION, AND CLINICAL SIGNIFICANCE
Jamie I. Vandenberg et al.
PHYSIOLOGICAL REVIEWS (2012)
Crystal Structure of a Lipid G Protein-Coupled Receptor
Michael A. Hanson et al.
SCIENCE (2012)
Investigation of the effect of molecular properties on the binding kinetics of a ligand to its biological target
Duncan C. Miller et al.
MEDCHEMCOMM (2012)
Trapping and dissociation of propafenone derivatives in HERG channels
A. Windisch et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Drug-target residence time: critical information for lead optimization
Hao Lu et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2010)
The dynamics of drug-target interactions: drug-target residence time and its impact on efficacy and safety
Robert A. Copeland
EXPERT OPINION ON DRUG DISCOVERY (2010)
Exploring Chemical Substructures Essential for hERG K+ Channel Blockade by Synthesis and Biological Evaluation of Dofetilide Analogues
Shagufta et al.
CHEMMEDCHEM (2009)
Substituted Terphenyl Compounds as the First Class of Low Molecular Weight Allosteric Inhibitors of the Luteinizing Hormone Receptor
Laura H. Heitman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Residence time of receptor-ligand complexes and its effect on biological function
Peter J. Tummino et al.
BIOCHEMISTRY (2008)
Computational models of the heart and their use in assessing the actions of drugs
Denis Noble
JOURNAL OF PHARMACOLOGICAL SCIENCES (2008)
The hERG potassium channel and hERG screening for drug-induced torsades de pointes
Jules C. Hancox et al.
PHARMACOLOGY & THERAPEUTICS (2008)
State dependent dissociation of HERG channel inhibitors
D. Stork et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
From drug target to leads-sketching a physicochemical pathway for lead molecule design in silico
S. A. Shaikh et al.
CURRENT PHARMACEUTICAL DESIGN (2007)
Quantifying the association and dissociation rates of unlabelled antagonists at the muscarinic M3 receptor
Mark R. Dowling et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Opinion - Drug-target residence time and its implications for lead optimization
Robert A. Copeland et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
hERG potassium channels and cardiac arrhythmia
MC Sanguinetti et al.
NATURE (2006)
Drug-induced torsades de pointes: The evolving role of pharmacogenetics
PT Fitzgerald et al.
HEART RHYTHM (2005)
Validation of a [3H]astemizole binding assay in HEK293 cells expressing HERG K+ channels
PJS Chiu et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2004)
Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development
WS Redfern et al.
CARDIOVASCULAR RESEARCH (2003)
Immobilized artificial membrane HPLC in drug research
A Taillardat-Bertschinger et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
[3H]dofetilide binding to HERG transfected membranes:: a potential high throughput preclinical screen
K Finlayson et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
ElogDoct:: A tool for lipophilicity determination in drug discovery.: 2.: Basic and neutral compounds
F Lombardo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
The physical chemistry of ligand-receptor binding identifies some limitations to the analysis of receptor images
KA Krohn
NUCLEAR MEDICINE AND BIOLOGY (2001)
HERG K+ channels: friend and foe
JI Vandenberg et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2001)
[3H]Dofetilide binding in SHSY5Y and HEK293 cells expressing a HERG-like K+ channel?
K Finlayson et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Molecular basis of functional voltage-gated K+ channel diversity in the mammalian myocardium
JM Nerbonne
JOURNAL OF PHYSIOLOGY-LONDON (2000)
分享论文
